You have no items in your cart.
New Agreement Set to Scale Up Production of Hem A Gene Therapy
Hemophilia News Today
ASC Therapeutics has joined forces with Charles River to scale the manufacturing of ASC618, its second-generation virus-based gene therapy for hemophilia A. The agreement expands upon their current collaboration, begun in ... Read more